Docusign (NASDAQ:DOCU) CEO Allan Thygesen Sells 26,250 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) CEO Allan Thygesen sold 26,250 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $46.02, for a total value of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at $7,318,928.76. The trade was a 14.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Price Performance

DOCU stock opened at $46.02 on Thursday. The business has a fifty day moving average price of $46.93 and a 200 day moving average price of $51.11. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $86.65. The stock has a market capitalization of $8.79 billion, a price-to-earnings ratio of 29.88, a P/E/G ratio of 1.31 and a beta of 0.90.

Docusign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, June 4th. The company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.10. The company had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.90 earnings per share. On average, equities analysts expect that Docusign Inc. will post 2.03 earnings per share for the current fiscal year.

Docusign declared that its board has initiated a share buyback plan on Tuesday, March 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to purchase up to 21% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Central Pacific Bank Trust Division bought a new stake in shares of Docusign during the fourth quarter worth approximately $25,000. Modus Advisors LLC acquired a new position in Docusign in the fourth quarter valued at approximately $27,000. Torren Management LLC bought a new position in Docusign in the fourth quarter valued at approximately $28,000. True Wealth Design LLC boosted its stake in Docusign by 105.2% in the fourth quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares during the last quarter. Finally, Aventura Private Wealth LLC bought a new stake in shares of Docusign during the 4th quarter valued at $30,000. Institutional investors own 77.64% of the company’s stock.

Key Headlines Impacting Docusign

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
• Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
• Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
• Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
• Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

Wall Street Analysts Forecast Growth

DOCU has been the topic of a number of research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a report on Friday, June 5th. JPMorgan Chase & Co. decreased their price target on shares of Docusign from $78.00 to $65.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 18th. Robert W. Baird lowered their price target on shares of Docusign from $75.00 to $55.00 and set a “neutral” rating for the company in a report on Wednesday, March 18th. Jefferies Financial Group boosted their price objective on shares of Docusign from $45.00 to $50.00 and gave the stock a “hold” rating in a research report on Friday, June 5th. Finally, Wall Street Zen raised Docusign from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 13th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $60.27.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.